Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression
0301 basic medicine
protein synthesis
Drug targets
Biotin synthetic pathway
2405 Parasitology
bacterial growth
bacterial protein
gene silencing
Mice
Drug Delivery Systems
sensitivity analysis
biotin
drug delivery system
animal
genetics
biotinylation
Biology (General)
bacteria
Bacteria (microorganisms)
quantitative analysis
Mus
2404 Microbiology
article
methodology
gene expression regulation
biotin derivative
unclassified drug
enzyme activity
3. Good health
tuberculosis
wild type
signal transduction
Research Article
570
in vitro study
QH301-705.5
enzymology
animal experiment
610
Biotin
animal tissue
in vivo study
03 medical and health sciences
BioA
1311 Genetics
Bacterial Proteins
1312 Molecular Biology
Animals
Tuberculosis
anhydrotetracycline
controlled study
BioA protein
7,8 diaminopelargonic acid synthase
mouse
Transaminases
Bacterial growth
2403 Immunology
nonhuman
doxycycline
aminotransferase
animal model
disease model
bacterial viability
Mycobacterium tuberculosis
RC581-607
Disease Models, Animal
Chronic Disease
Mutation
2406 Virology
Murinae
biosynthesis
mutation
Immunologic diseases. Allergy
chronic disease
metabolism
DOI:
10.1371/journal.ppat.1002264
Publication Date:
2011-09-29T17:37:31Z
AUTHORS (12)
ABSTRACT
In the search for new drug targets, we evaluated biotin synthetic pathway of Mycobacterium tuberculosis (Mtb) and constructed an Mtb mutant lacking biosynthetic enzyme 7,8-diaminopelargonic acid synthase, BioA. biotin-free media, ΔbioA did not produce wild-type levels biotinylated proteins, therefore grow lost viability. was also unable to establish infection in mice. Conditionally-regulated knockdown strains similarly exhibited impaired bacterial growth viability vitro mice, irrespective timing transcriptional silencing. Biochemical studies further showed that BioA activity has be reduced by approximately 99% prevent growth. These thus de novo synthesis is essential maintain a chronic murine model TB. Moreover, these provide experimental strategy systematically rank vivo value potential targets other pathogens.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (122)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....